Indication

Recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient

Recurrent mucocutaneous herpes simplex in a human immunodeficiency virus (HIV)–infected patient refers to repeated episodes of symptomatic herpes simplex virus (HSV-1 or HSV-2) reactivation affecting the mucous membranes and adjacent skin, predominantly in the oral, genital, or perianal regions. Read more about Recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient

17 drugs 17 manufacturers

Advertisement

Drugs that treat it

Common Recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient therapies.

Showing 1–9 of 17 drugs

FAMCICLOVIR

ANTIVIRAL - HERPES VIRUSES·HERPES ZOSTER·+4
AUROBINDO PHARM

FAMCICLOVIR

ANTIVIRAL - HERPES VIRUSES·HERPES ZOSTER·+4
Mylan Pharmaceuticals

FAMCICLOVIR

ANTIVIRAL - HERPES VIRUSES·HERPES ZOSTER·+4
TEVA USA

FAMCICLOVIR

ANTIVIRAL - HERPES VIRUSES·HERPES ZOSTER·+4
APOTEX CORP

FAMCICLOVIR

ANTIVIRAL - HERPES VIRUSES·HERPES ZOSTER·+4
MACLEODS PHARMA

FAMCICLOVIR

ANTIVIRAL - HERPES VIRUSES·HERPES ZOSTER·+4
CAMBER PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient.

Recurrent mucocutaneous herpes simplex in a human immunodeficiency virus (HIV)–infected patient refers to repeated episodes of symptomatic herpes simplex virus (HSV-1 or HSV-2) reactivation affecting the mucous membranes and adjacent skin, predominantly in the oral, genital, or perianal regions.

Impaired cell-mediated immunity from HIV infection leads to more frequent, prolonged, and severe outbreaks compared to immunocompetent hosts.

Clinically, it presents as clusters of painful vesicles that progress to erosions or deep, slowly healing ulcerative lesions, which carry an increased risk of tissue necrosis and secondary bacterial infection.

Personalize your experience

Follow Recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it